This week’s newsletter covers the latest plant medicine research, including hemp flour’s nutritional benefits in baking, myrcene’s neuroprotective potential, engineered fungi producing cannabinoids, and cannabinoid combinations showing promise for neuropathy and inflammatory bowel disease.
Noteworthy Read
Enriching Wheat Bread With Hemp Flour (PubMed)
In a recent study, researchers showed that adding hemp flour to wheat bread increased its protein, fiber, and antioxidant content while maintaining acceptable texture and flavor. The study suggests hemp flour is a nutritionally valuable and functional ingredient for bakery products.
Read more
View more in CBD
More Noteworthy Reading
Myrcene — a Prominent Cannabis Terpene — Treats Mild Traumatic Brain Injury (PubMed)
A preclinical study found that myrcene improved neurological outcomes in mice with mild traumatic brain injury by reducing inflammation and oxidative stress. The terpene also appeared to support neuronal recovery, suggesting potential neuroprotective applications.
Read more
View more in Endocannabinoid System
Cannabinoid Biosynthesis via Engineered Fungi (PubMed)
This study demonstrates that genetically engineered fungi can produce cannabinoids such as CBGA and other precursors, potentially offering a scalable biotechnological alternative to plant-based extraction.
Read more
View more in Synthetic Cannabinoids
Research Round-Up
Combining CBD/THC to Manage Chemotherapy-Induced Peripheral Neuropathy (PubMed)
A new review highlights that combining CBD and THC shows strong potential for reducing chemotherapy-induced peripheral neuropathy. The cannabinoids work through anti-inflammatory, antioxidant, and neuroprotective mechanisms, with evidence suggesting they may reduce neuropathic pain and prevent nerve damage when used together.
Read more
View more in THC
CBD Combined With THCV Alleviates Colitis in Mice via CB2 Receptor (PubMed)
Researchers found that the combination of CBD and THCV significantly reduced inflammation and tissue damage in a mouse model of colitis. The therapeutic effect depended on CB2 receptor activation, pointing to a promising cannabinoid-based strategy for inflammatory bowel disease.
Read more
View more in Endocannabinoid System
A heartfelt thank you to all of the CBD brands whose generous support fuels Project CBD’s mission to bring you the most important emerging plant medicine research each and every week.
Be the first to comment